| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |